The Northern Ireland Biobank (NIB) is a collaborative project between Queens University Belfast (QUB) and the Belfast Health and Social Care Trust (BHSCT). The vision of the biobank is to host and distribute collections of well defined, quality assured biological samples to support translational research programmes in Northern Ireland and beyond.
Financial support for the NIB has been secured from HSC R & D Division of the Public Health Agency, Cancer Research-UK and the Belfast Friends of the Cancer Centre. Queens University is the host institution. The NIB Steering Committee oversees the good practices of the bank.
NIB has approval from ORECNI (reference 16/NI/0030) to collect, store and distribute samples to researchers. NIB has created retrospective collections facilitating construction of bespoke tissue microarrays (TMAs) and DNA libraries for particular cancer types. Tumour blocks have been arrayed across multiple cancer types. NIB prospective collections commenced in late 2011 of tumour and non-tumour control tissues together with patient-matched blood samples and derivatives, urine and other bodily fluids when appropriate. To date, NIB prospective collections have focused on gastrointestinal, breast, genitourinary gynaecological and haematological malignancies; though NIB has flexibility to collect all cancer types as well as samples of tissues and blood from individuals with premalignant or potentially malignant conditions. NIB functions under the QUB Human Tissue Authority Research Licence (12044).
NIB is a member of the International Society for Biological and Environmental Repositories (ISBER), the European Society for Biobanking and Biopreservation (ESBB) and is registered with the UK CRC Tissue Directory.
OREC NI Report
Annual Report to Research Ethics Committee now available to read online
Access policy now available to read online